Summary
A GLC method has been developed to measure chlorophenoxyisobutyric acid in plasma after benzol extraction and transformation to its methyl ester, using methyl laurate as the internal standard. Plasma free fatty acids did not interfere with the analysis, but it could not be employed in the presence of salicylates. The method has been employed to study the pharmacokinetics of chlorophenoxyisobutyric acid in man after oral ingestion of a single dose of clofibrate.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Barrett, A.M.: The effect of chlorophenoxyisobutyric acid on the release of free fatty acids from isolated adipose tissue in vitro. Brit. J. Pharmacol.26 363–371 (1966)
Barrett, A.M., Thorp, J.M.: Studies on the mode of action of clofibrate: effect on hormone-induced changes in plasma free fatty acids, cholesterol, phospholipids and total esterified fatty acids in rats and dogs. Brit. J. Pharmacol.32 381–391 (1968)
Beaumont, J.L., Dachet, C.: Lipoprotéines du serum et médicaments hypolipémiants apparentés au clofibrate. Atherosclerosis17 419–433 (1973)
Berson, S.A., Yallow, R.S., Schreider, S.S., Pot, J.: Tracer experiments with I131 labelled human serum albumin: distribution and degradation studies. J. clin. Invest.32 746–768 (1953)
Chasseaud, J., Cooper, A.J., Saglers, V.H.: Plasma concentration and bioavailability of clofibrate after administration to human subjects. J. clin. Pharmacol.14 382–391 (1974)
Coffey, J.J., Bullock, F.J., Schoenemann, P.T.: Numerical solution of non linear pharmacokinetic equations: effect of plasma protein binding on drug distribution and elimination. J. pharm. Sci.60 1623–1628 (1971)
Dost, F.H.: An explicit function for rate constant of entrance concerning a two-compartment model. Advances in the Biosciences 5. Oxford: Pergamon Press 1970
Frederickson, D.F., Levy, R.I., Lees, R.R.: Fat transport in lipoprotein: an integrated approach to mechanisms and disorders. New Engl. J. Med.276 215–219 (1967)
Nelson, E.: Kinetics of drug absorption, distribution, metabolism and excretion. J. pharm. Sci.50 181–191 (1961)
Oliver, M.F.: Further observations on the effect of Atromid and of ethylchlorophenoxyisobutyrate on serum lipid levels. J. Atheroscler. Res.3 427–444 (1963)
O'Reilly, R.A., Aggeler, P.M., Leong, L.S.: Studies on the coumarin anticoagulant drugs: the pharmacodynamics of warfarin in man. J. clin. Invest.42 1542–1551 (1963)
Thorp, J.M.: Experimental evaluation of an orally active combination of androsterone with ethyl chlorophenoxyisobutyrate. Lancet1962 I, 1323–1326
Thorp, J.M., Waring, W.S.: Modification of metabolism and distribution of lipids by ethylchlorophenoxyisobutyrate. Nature (Lond.),194 948–949 (1962)
Tillement, J.P., Zini, R., D'Athis, P., Vassent, G.: Binding of certain acidic drugs to human albumin: theoretical and practical estimation of fundamental parameters. Eur. J. clin. Pharmacol.7 307–313 (1974)
Tillement, J.P., Thébault, J.J. Mattei, C., D'Athis, P., Blatrix, C.: Anticoagulant effect and plasma kinetics of fluorophenindione after a single dose in man. Eur. J. clin. Pharmacol.8 271–275 (1975)
Tuong, C.C.: personal communication (1974)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Houin, G., Thébault, J.J., d'Athis, P. et al. A GLC method for estimation of chlorophenoxyisobutyric acid in plasma. Pharmacokinetics of a single oral dose of clofibrate in man. Eur J Clin Pharmacol 8, 433–437 (1975). https://doi.org/10.1007/BF00562318
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00562318